Innodem Neurosciences

About:

Mobile eye-tracking technology for better healthcare

Website: https://innodemneurosciences.com/

Twitter/X: InnodemNeuro

Top Investors: Centech, Morningside Venture Investments

Description:

Innodem Neurosciences is committed to improving the quality of life for patients, and effectiveness of healthcare. Our mobile eye-tracking technology allows patient self-testing to help clinicians monitor disease progression and adapt treatments accordingly. We are defining a new standard of patient-centric medical assistance for better healthcare.

Total Funding Amount:

$6.77M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2016-01-01

Founders:

Etienne de Villers-Sidani, Marc Reeves, Yves Desgagné

Number of Employees:

11-50

Last Funding Date:

2021-01-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai